Centrum 7/6  banner

S&P Capital IQ

Outlook: Transition time for drug chains

Outlook: Transition time for drug chains

NEW YORK — Going forward, chain drug stores can bank on the same underlying trends that have fueled the retail pharmacy business in recent years. But the industry as they’ve known it won’t look quite the same. Retailer consolidation, changes in drug purchasing and the influx of specialty drugs are reshaping the competitive arena, industry

PP_1170x120_10-25-21